The Pharma Letter Privately-held Spanish drugmaker Ferrer Internacional says that it has successfully completed a Phase III clinical trial in adult and paediatric patients with impetigo involving Ozenoxacin formulated as a topical treatment for dermatological infectious ... and more »
Sacramento Bee Please contact Publicist - Amber Clapp – 646-567-8114 or amberclapp@yahoo.com About EnaltusTM EnaltusTM (www.enaltus.com), a dermatological products company headquartered in Suwanee, Ga., focuses on providing high-quality skin care products ... and more »
Zenopa Galderma is to expand its portfolio of muscle relaxant products with the development of a new agent based on an advanced formulation of botulinum toxin. The first cohort of patients have already been treated in an initial clinical study of the drug ...
DailyFinance Dr. Craig Dees, PhD, CEO of Provectus, noted, "Rose Bengal has had a long and colorful history, starting in the 19th century as a humble synthetic wool dye, then being used throughout the 20th century as a food dye and in several diagnostic agents . The ...
PR Web (press release) Axia Medical Solutions, the maker of the popular anti-aging skin care line Dermesse, has introduced a new treatment to their physician-administered product line. It is called the RADIANT PEEL, and it includes a combination of TCA, Salicylic Acid ... and more »
